634 related articles for article (PubMed ID: 32807134)
21. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
[TBL] [Abstract][Full Text] [Related]
22. HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3.
Yuan K; Lei Y; Chen HN; Chen Y; Zhang T; Li K; Xie N; Wang K; Feng X; Pu Q; Yang W; Wu M; Xiang R; Nice EC; Wei Y; Huang C
Cell Death Differ; 2016 Apr; 23(4):616-27. PubMed ID: 26794444
[TBL] [Abstract][Full Text] [Related]
23. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.
Liu M; Yan Q; Sun Y; Nam Y; Hu L; Loong JH; Ouyang Q; Zhang Y; Li HL; Kong FE; Li L; Li Y; Li MM; Cheng W; Jiang LX; Fang S; Yang XD; Mo JQ; Gong YF; Tang YQ; Li Y; Yuan YF; Ma NF; Lin G; Ma S; Wang JG; Guan XY
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6103-6113. PubMed ID: 32123069
[TBL] [Abstract][Full Text] [Related]
24. Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma.
Han W; Yu G; Meng X; Hong H; Zheng L; Wu X; Zhang D; Yan B; Ma Y; Li X; Wang Q
Mol Cell Biochem; 2019 Oct; 460(1-2):37-51. PubMed ID: 31222560
[TBL] [Abstract][Full Text] [Related]
25. HN1 as a diagnostic and prognostic biomarker for liver cancer.
Liu Z; Yang D; Li Y; Jiao Y; Lv G
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32700728
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
27. Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression.
Mello T; Materozzi M; Zanieri F; Simeone I; Ceni E; Bereshchenko O; Polvani S; Tarocchi M; Marroncini G; Nerlov C; Guasti D; Bani D; Pinzani M; Galli A
Int J Cancer; 2020 Jun; 146(12):3410-3422. PubMed ID: 31721195
[TBL] [Abstract][Full Text] [Related]
28. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Zhang D; Duan Y; Wang Z; Lin J
Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
[TBL] [Abstract][Full Text] [Related]
29. SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation.
Khan MGM; Boufaied N; Yeganeh M; Kandhi R; Petkiewicz S; Sharma A; Yoshimura A; Ferbeyre G; Labbé DP; Ramanathan S; Ilangumaran S
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765862
[TBL] [Abstract][Full Text] [Related]
30. Suppressor of cytokine signaling (SOCS) genes are downregulated in breast cancer.
Ghafouri-Fard S; Oskooei VK; Azari I; Taheri M
World J Surg Oncol; 2018 Nov; 16(1):226. PubMed ID: 30453988
[TBL] [Abstract][Full Text] [Related]
31. EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling.
Liu ZK; Li C; Zhang RY; Wei D; Shang YK; Yong YL; Kong LM; Zheng NS; Liu K; Lu M; Liu M; Hu CX; Yang XZ; Chen ZN; Bian H
Mol Cancer; 2021 May; 20(1):79. PubMed ID: 34044846
[TBL] [Abstract][Full Text] [Related]
32. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
[TBL] [Abstract][Full Text] [Related]
33. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
34. MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis.
Chen Q; Yin D; Zhang Y; Yu L; Li XD; Zhou ZJ; Zhou SL; Gao DM; Hu J; Jin C; Wang Z; Shi YH; Cao Y; Fan J; Dai Z; Zhou J
Cell Death Dis; 2017 Jun; 8(6):e2906. PubMed ID: 28661477
[TBL] [Abstract][Full Text] [Related]
35. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
[TBL] [Abstract][Full Text] [Related]
36. The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma.
Zhao R; Chen K; Zhou J; He J; Liu J; Guan P; Li B; Qin Y
Medicine (Baltimore); 2017 Mar; 96(12):e6420. PubMed ID: 28328845
[TBL] [Abstract][Full Text] [Related]
37. Polymeric immunoglobulin receptor (PIGR) exerts oncogenic functions via activating ribosome pathway in hepatocellular carcinoma.
Zhang Y; Zhang J; Chen X; Yang Z
Int J Med Sci; 2021; 18(2):364-371. PubMed ID: 33390805
[No Abstract] [Full Text] [Related]
38. Therapeutic Potential for Targeting the Suppressor of Cytokine Signalling-1 Pathway for the Treatment of SLE.
Sukka-Ganesh B; Larkin J
Scand J Immunol; 2016 Nov; 84(5):299-309. PubMed ID: 27781323
[TBL] [Abstract][Full Text] [Related]
39. Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.
Chevrier M; Bobbala D; Villalobos-Hernandez A; Khan MG; Ramanathan S; Saucier C; Ferbeyre G; Geha S; Ilangumaran S
BMC Cancer; 2017 Feb; 17(1):157. PubMed ID: 28235401
[TBL] [Abstract][Full Text] [Related]
40. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
